2026-01-01 - Analysis Report
Okay, here's a breakdown of the CRM data you provided, with simple numbers first, followed by a basic analysis for each section, and finally a comprehensive summary.

**0) Report Language: English**

**1) Return Rate Comparison: CRM vs. S&P 500 (VOO)**

*   **Company Overview:** Salesforce Inc. (CRM) is a cloud-based software company providing customer relationship management (CRM) services.
*   **CRM Cumulative Return:** -1.89%
*   **VOO Cumulative Return:** 102.21%
*   **Divergence:** (max: 54.1, min: -116.9, current: -104.1, relative divergence: 7.5)

**Analysis:** CRM has significantly underperformed the S&P 500 (VOO) over the period examined. The divergence is substantial (-104.1%), and the relative divergence of 7.5 indicates it is at the very bottom end of its historical divergence range.

**Alpha, Beta Analysis Table:**

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2024-2026  | 2.0% | 76.6% | -103.0% | -0.0 | 252.5 |

**Analysis:** The table highlights key performance indicators for CRM.
* CAGR (Compound Annual Growth Rate) indicates a modest growth of 2.0%.
* MDD (Maximum Drawdown) shows a significant potential loss of 76.6%.
* Alpha is deeply negative at -103.0%, suggesting significant underperformance relative to a benchmark.
* Beta is -0.0, which is a very low correlation to the market.
* Cap(B) (Market Capitalization in Billions) is 252.5.

**2) Recent Stock Price Fluctuations:**

*   **Close:** 265.92
*   **Last Market Data:** Price: 265.24, Previous Close: 265.92, Change: -0.26
*   **5-day SMA:** 265.384
*   **20-day SMA:** 259.0656
*   **60-day SMA:** 248.8942

**Analysis:** The 5-day SMA is slightly above the current price, while the 20-day and 60-day SMAs are significantly lower. This suggests a recent upward trend, but it may be losing momentum. The negative change from the previous close indicates a slight downward pressure.

**3) Index Indicators and Delta_Previous_Relative_Divergence, Expected_Return**

*   **Market Risk Indicator (MRI):** 0.9 (Medium Investment Recommended)
*   **RSI:** 58.83 (Neutral)
*   **PPO:** 0.1863
*   **Hybrid Signal:** cash_0%_Buy 90% of cash (4 shares - Safe - MRI:0.80) (Cash Ratio: 0% on 2025-12-02)
*   **Recent (20 days) relative divergence change:** -0.1 (Short-term decline)
*   **Expected Return (%):** -597.7% (Long-term underperformance vs. S&P 500)

**Analysis:**
*   The MRI suggests a medium level of investment risk.
*   The RSI is neutral, not indicating overbought or oversold conditions.
*   The PPO (Percentage Price Oscillator) measures the momentum of a stock.
*   The hybrid signal suggest to buy 90% of the cash with only 4 shares.
*   The negative change in relative divergence indicates a short-term decline.
*   The drastically negative expected return is a major red flag, suggesting significant underperformance compared to the S&P 500 if held long-term. The comment regarding the fluctuation issue suggests volatility, and the magnitude of the price change should be watched.

**4) Recent News & Significant Events (Yahoo Finance):**

*   **[2025-12-31] Salesforce Stock Now 27% Cheaper, Time To Buy - Trefis**
*   **[2025-12-04] Salesforce Earnings Might Have Been Good Enough to End Its Stock’s 3 Quarter Losing Streak - Barron's**
*   **[2025-12-28] Salesforce (CRM) Stock Today: Weekend Headlines, Analyst Price Targets, and What to Watch Before Monday’s Market Open - ts2.tech**
*   **[2025-12-31] CRM's Agentforce ARR Jumps 330% Y/Y: Is It the Next Growth Engine? - TradingView**
*   **[2025-12-30] Is Trending Stock Salesforce Inc. (CRM) a Buy Now? - Yahoo Finance Singapore**
*   **[2025-12-29] Agentforce Sets Bullish Tempo For Salesforce Stock (CRM) - TipRanks**

**Analysis:** The news headlines present a mixed picture. Some articles suggest a buying opportunity due to the stock being "cheaper" and potentially ending a losing streak. However, the articles also highlight the Agentforce ARR growth, which could be a positive sign for future growth. Overall, the news is cautiously optimistic, but requires deeper investigation.

**4-2) Analyst Opinions:**

*   **Consensus:** Buy
*   **Mean Rating:** 1.64 (~Buy)
*   **Opinions:** 53
*   **Target Price (avg/high/low):** 330.06 / 475.00 / 223.00
*   **Recent Rating Changes:** Not specified in detail.

**Analysis:** Analysts generally have a positive outlook on CRM, with a consensus rating of "Buy". The average target price is significantly higher than the current price, suggesting potential upside. However, the wide range between the high and low target prices indicates uncertainty. The absence of specific rating changes makes it difficult to assess recent shifts in analyst sentiment.

**5) Recent Earnings Analysis:**

| 날짜       | EPS  | 매출       |
|------------|------|------------|
| 2025-12-04 | 2.2  | 10.26 B$   |
| 2025-09-04 | 1.97 | 10.24 B$   |
| 2025-05-29 | 1.61 | 9.83 B$    |
| 2024-12-04 | 1.6  | 9.44 B$    |
| 2025-12-04 | 1.6  | 9.44 B$    |

**Analysis:** Both EPS (Earnings Per Share) and Revenue have generally been increasing over the past few quarters. The latest EPS figure shows a noticeable jump, and revenue is also trending upward. This is a positive sign for the company's financial performance. There's an error in the table with two entries for 2024-12-04, the first should be 2024-12-04, the second should be 2025-12-04.

**6) Financial Information:**

**Revenue and Profitability:**

| Quarter      | Revenue  | Profit Margin |
|--------------|----------|----------------|
| 2025-10-31   | $10.26B  | 78.02%         |
| 2025-07-31   | $10.24B  | 78.10%         |
| 2025-04-30   | $9.83B   | 76.96%         |
| 2025-01-31   | $9.99B   | 77.81%         |
| 2024-10-31   | $9.44B   | 77.71%         |

**Capital and Profitability:**

| Quarter      | Equity   | ROE      |
|--------------|----------|----------|
| 2025-10-31   | $60.02B  | 3.48%    |
| 2025-07-31   | $61.33B  | 3.08%    |
| 2025-04-30   | $60.67B  | 2.54%    |
| 2025-01-31   | $61.17B  | 2.79%    |
| 2024-10-31   | $58.52B  | 2.61%    |

**Analysis:**
* **Revenue & Profitability:** Revenue is growing consistently, and profit margins are very high and relatively stable around 77-78%.
* **Capital & Profitability:** Equity is fluctuating, and ROE (Return on Equity) is also fluctuating, but the latest quarter shows a notable increase. This suggests improved profitability relative to shareholder equity.

**7) Comprehensive Analysis (Summary):**

CRM has significantly underperformed the S&P 500, with a large negative divergence. Recent performance indicators (CAGR, MDD, Alpha, Beta) reveal a concerning picture, marked by underperformance and high risk. While recent earnings and revenue figures show positive trends, the exceptionally negative expected return raises serious concerns about long-term investment prospects. Analyst consensus is "Buy" with a higher price target, but the wide range suggests uncertainty. The news is a mixed bag, but positive analyst ratings suggest positive upside. Agentforce growth could be a catalyst.

**In Conclusion:** While recent financial performance indicators are trending positively, the significant underperformance relative to the S&P 500 and the deeply negative expected return warrant caution. A deeper investigation is needed to understand the reasons behind the underperformance and assess the long-term potential of the stock.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.